Search Results 821-830 of 20857 for medication and sexual functioning

  1. Pazopanib in Treating Patients with Metastatic Non-Clear Cell Kidney Cancer - Mayo Clinic

    Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2 ... Complete abstinence from sexual intercourse for ... medication for 6 months prior to ...

  2. Octreotide (oral route) - Side effects & dosage - Mayo Clinic

    ... medication or change some of the other medicines you take. ... Do not keep outdated medicine or medicine ... loss in sexual ability, desire, drive, or performance ...

  3. Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer - Mayo Clinic

    By condition, treatment or drug name. Search tips ... ECOG performance status 0-1. Patients must be ... sexual intercourse during the treatment period ...

  4. Acyclovir (topical route) - Side effects & dosage - Mayo Clinic

    Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding. Drug Interactions. Although certain medicines ...

  5. Conjugated estrogens and medroxyprogesterone (oral route) - Side effects & dosage - Mayo Clinic

    ... medication or change some of the other medicines you take. ... Do not keep outdated medicine or medicine ... loss in sexual ability, desire, drive, or performance ...

  6. Sirolimus (oral route) - Side effects & dosage - Mayo Clinic

    loss of sexual ability, desire, drive, or performance; loss of voice; muscle pain; nasal congestion; nausea or vomiting; numbness or tingling around the lips ...

  7. Cardiovascular Medicine - Clinical trials

    The purpose of this study is to determine how many patients suffer from sexual function problems and ascertain if they are improved or modified by cardiac ...

  8. Betaxolol (oral route) - Side effects & dosage - Mayo Clinic

    loss in sexual ability, desire, drive, or performance; muscle pain or stiffness; rash; runny nose; sleeplessness; sneezing; stomach discomfort, upset, or pain ...

  9. Dose-Escalation Study of cevostamab (BFCR4350A) in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) - Mayo Clinic

    By condition, treatment or drug name. Search tips ... Serum free light chain (SFLC) assay. Laboratory values as follows: Hepatic function ... The reliability of ...

  10. Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects with Nonresectable or Metastatic IDH1-Mutant Cholangiocarcinoma - Mayo Clinic

    Women of childbearing potential (WOCBP) must agree to abstain from sexual ... Adequate haematological function ... For prior and forbidden concomitant medication, ...